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Abstract
Towards preparing porphyrin complexes that combine contrast agent and
photodynamic therapy capabilities at tumor sites, the Gd(III) porphyrin
derivative of the octabrominated meso-tetrakis(N-methyl-4-pyridyl)porphyrin,
GdTMPyPBr85+ was synthesized by refluxing Gd(III) ion with H3TMPyPBr85+ at
pH 7. The metallocomplex was characterized by UV-visible spectroscopy and
showed a Soret band shift from 503 nm to 463 nm at pH 7, suggesting that metal
insertion of Gd(III) into the core of porphyrin ligand had occurred. However,
synthesis of the Gd(III) complex required high temperatures and long reaction
times. To circumvent these harsh conditions, the lithium porphyrin derivative
was first prepared and subsequently combined with Gd(III) ion to yield the
desired product at room temperature.
INTRODUCTION
Cancer is the number two killer in the U.S. just after heart disease. Recent
statistics show that 1 in 4 deaths in the United States are due to cancer.1 Current
treatments for cancer and harmful tumors include chemotherapy, radiation, and
surgery. However, these treatments are invasive in nature and may produce a
number of negative side effects. Photodynamic therapy (PDT), a relatively new
mode for cancer treatment, combines a light source and a photosensitizing agent
to destroy targeted cells through a photodynamic effect. The photosensitizer is
an organic compound that is activated when exposed to light as demonstrated in
Figure 1.2
Photodynamic Therapy
Figure 1 shows that exposure of the photosensitizer to light of appropriate
wavelengths causes energy transitions from the electronic ground state (So) to
excited singlet energy states (S1, etc). The fate of this excited energy depends
on the photosensitizer - energy can be emitted as fluorescence (kf) and in some
cases, intersystem crossing (ISC) to triplet excited energy states can result in
phosphorescence (kp). The goal of PDT is for the transfer of excitation energy to
molecules such as oxygen to form singlet oxygen (1O2) or other reactive species
(•O2-) that are cytotoxic to cancer and tumor cells.2
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Figure 1. Photosensitization of oxygen represented as a Jablonski diagram
The photosensitizing agent in PDT is a critical component of the treatment.
Consequently, porphyrins are currently under intense investigation as
photosensitizing agents.
Porphyrins and Photodynamic Therapy
Porphyrins are cyclic organic compounds that possess four alternating pyrrole
rings and two acidic core protons.3 From a structural perspective, porphyrins
are derived from the parent porphyrin “porphine” that is comprised of four
alternating pyrrole rings with four methane bridges (Figure 2). Porphyrins
consist of 22 π-electrons and 18 contribute to the aromatic system. Porphyrins
are highly conjugated systems that strongly absorb visible light. These aromatic
macrocyles exhibit a diagnostic optical spectrum due to π-π* transitions. At
approximately 400 nm, porphyrins exhibit an intense Soret band (extinction
coefficients ~ 105 cm-1M-1) and less intense Q-bands between 500 and 700
nm. A key characteristic of porphryin is that the conjugated structure allows
for substitution at the β- and γ-carbons. In addition, metalloporphyrins can be
prepared by substitution of metal ions for porphyrin’s core protons.
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Figure 2. Porphine structure
Our interest in porphryins centers on their application as contrast agents in
magnetic resonance imaging (MRI) and their potential as photosensitizers in
the photodynamic therapy of tumor and cancer cells. Porphyrins absorb visible
light strongly and at long wavelengths (> 600 nm) necessary for penetration of
photons through deep tissue, they have demonstrated selective accumulation in
tumors, low level or dark toxicity, and general lack of severe side effects and
disfigurement of patients.4 At the same time, Photofrin®, the first porphyrinbased PDT treatment to win approval in the U.S., Canada, Japan, and Europe,
has one major limitation – it accumulates in the skin for up to six weeks,
rendering patients photosensitive especially to strong sunlight.5 Plus, the longest
wavelength at which Photofrin® can be photo-activated is 630 nm which is
within the general absorption profile of hemoglobin, an abundant pigment in
blood. This limits Photofrin’s® therapeutic application.
Porphyrins and Magnetic Resonance Imaging Gadolinium(III) Contrast Agents
At present, four non-porphyrinic gadolinium(III) MRI contrast agents have been
approved for clinical use since the gadolinium(III) ion provides high quality
enhancement of internal images in the human body.6 However, Gd(III) contrast
agents have been linked to negative health issues such as Nephrogenic Systemic
Fibrosis, a rare disease that causes hardening of skin, joints, eyes, and internal
organs.7 Recent studies suggest that Zn(II), Cu(II), and Ca(II) ions in vivo
compete for the binding site of the organic ligand to which the Gd(III) ion is
bound via a transmetallation reaction that releases the acutely toxic lanthanide
ion.8 However, other reports demonstrate stability of the metal ion in other
porphyrin-based ligands.9
MOTIVATION
We recently reported10 the synthesis of the Gd(III) derivative of a novel
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octabrominated water-soluble porphyrin, 2,3,7,8,11,12,17,18-octabromomeso-tetrakis(N-methyl-4-pyridyl)porphyrin, H3TMPyPBr85+ because of our
interest in combining the tumor accumulation and photosensitizing properties
of porphyrins with the contrast agent enhancement capability of Gd(III) ions.
While most porphyrins are near planar, the H3TMPyPBr85+ exhibited a saddleshaped structure with a core that appears large enough to form a stable complex
with the large ionic radius of the Gd(III) ion (~108 pm). Although we have
successfully synthesized the GdTMPyPBr85+ complex, reaction at pH 7 required
long reflux times (100oC, > 24 h) (equation 1), reducing the cost-effectiveness of
the product.
H3TMPyPBr85+ + Gd3+ = GdTMPyPBr85+ + 3 H+
(1)
Arnold and others10 have demonstrated the ease of synthesizing lanthanide
porphyrin complexes by reaction between lithium porphyrins and lanthanide
ions such as ytterbium(III) ions (equation 2). However, manipulation of these
materials required air-sensitive environments.
2 Li2P
+
Yb3+
= YbP2+ 4 Li+
(2)
We were the first to show that a stable mono-lithium complex, LiTMPyBr83+,
could exist in aqueous basic media (equation 3).11
H3TMPyPBr85+ + 2 Li+ = (LiTMPyPBr83+) Li+ + 3 H+
(3)
Therefore, transmetallation of the lithium complex should provide a pathway for
the preparation of the Gd(III) porphyrin complex at room temperature (equation
4).
LiTMPyPBr83+ + Gd3+ = GdTMPyPBr85+ + Li+
(4)
To enhance this reactivity in aqueous and nonaqueous solutions, we recently
isolated the air-stable lithium ion porphyrin complex as a red solid at room
temperature via metathesis of lithium hexafluorophosphate and the free base
octabromoporphyrin.
MATERIALS AND METHODS
Synthesis of GdTMPyPBr85+ was achieved via reaction of H3TMPyPBr85+
and Gd (III) ion using the methods of Richards et al.10 The reaction progress
was monitored by UV-visible spectroscopy using a Shimadzu UV2401PC
spectrophotometer. meso-Tetrakis(N-methyl-4-pyridyl)porphyrin, H2TMPyP4+,
was purchased as the 4-toluenesulfonate (OTs-) salt from Frontier Scientific,
Inc. Ammonium hexafluorophosphate (NH4PF6), lithium hexafluorophosphate
(LiPF6), bromine (Br2), dimethylformamide (DMF), gadolinium(III) chloride
(GdCl3) and acetate (GdOAc3), and tetrabutylammonium chloride (NBu4Cl)
were purchased from Sigma Aldrich. All other reagents, including metal salts,
were purchased from Sigma-Aldrich and used without further modification.
Synthesis of H3TMPyPBr85+
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To 0.239 g (0.175 mmol) of H2TMPyP4+ was added an equimolar quantity of
cupric acetate (Cu(CH3COO)2; 0.0401 g) in 20 mL of methanol. The solution
was refluxed for 2 hrs resulting in an initial color change of the solution from
purple to dark red (Scheme 1). The mixture was cooled and the solvent removed
via distillation. The red solid was collected by suction filtration and air-dried
without further purification.

Scheme 1. Synthesis of CuTMPyP4+
The reaction was monitored by UV-visible spectroscopy (Figure 3).

425 nm

Figure 3. Absorption spectrum of CuTMPyP4+ (pH 7)
Next, approximately 0.35 g of the product was dissolved in 25 mL DMF. While
stirring, 12 mL of Br2 solution (1 mL Br2 in 11 mL DMF) was added drop-wise
over a time span of 30 minutes. Upon exposure to Br2, the solution slowly
transitioned from a red solution to a dark green solution and was allowed to stir
for an additional 24 hrs as shown in Scheme 2.
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Scheme 2. Bromination of CuTMPyP4+
The resulting solution was vacuum filtered, resulting in a green powder that was
air-dried. The product was characterized via UV-Vis spectroscopy (Figure 4).
457 nm

Figure 4. Absorption spectrum of CuTMPyPBr84+ (pH 7)
The resulting CuTMPyPBr84+ was dissolved in 10 mL of concentrated sulfuric
acid to demetallate the Cu(II) ion. The solution changed to a dark brown color
and red vapors were evident. After stirring for 30 min, approximately 50 mL of
ice was poured into the solution and allowed to stir gently. Once the ice started
to melt, excess NH4PF6 was added resulting in the formation of a precipitate
(Scheme 3). Suction filtration produced a black-brown solid that was washed
several times with deionized water and allowed to air-dry overnight.
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Scheme 3. Demetallation of Cu(II) ion to prepare H3TMPyPBr85+
The product was observed by absorption spectroscopy (Figure 5).

503 nm

Figure 5. Absorption spectrum of H3TMPyPBr85+ (pH 7)
Synthesis of GdTMPyPBr85+
To 0.352 g of H3TMPyPBr85+ was added an equimolar GdCl3 (0.0103g) in 15
mL of water at pH 7. The reaction was refluxed for 24 h and the solution color
changed from a black-brown solution to a dark green solution (Scheme 4) as
previously reported.
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Scheme 4. Synthesis of GdTMPyPBr85+
The solution was filtered via suction filtration and the solid was collected and air
dried. The absorption spectrum is shown in Figure 6.

463 nm

Figure 6. Absorption spectrum of target molecule, GdTMPyPBr85+ (pH 7)
Synthesis of GdTMPyPBr85+ via LiTMPyPBr83+
The LiTMPyPBr83+ was prepared via metathesis of the deprotonated freebase
porphyrin, TMPyPBr82+, with lithium ion in basic solution. To a clean glass vial
charged with 5 mL of 0.1M NaOH (pH 11) was added approximately 1 mg of
the chloride salt of H3TMPyPBr85+ forming a purple solution (Scheme 5).
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0.1 M NaOH

H3TMPyPBr85+
λmax 503 nm

TMPyPBr82+
λmax 579 nm

Scheme 5. Synthesis of the deprotonated free base porphyrin at pH 11.
Thereafter, the LiTMPyPBr83+ complex was prepared and isolated as the PF6salt using two different routes. (1) Excess LiCl was added to the basic solution
of the TMPyPBr82+ followed by addition of excess NH4PF6. The solution color
immediately changed from purple to red. Formation of the red precipitate was
slow (~ 1 h). The solid was collected by passing the mixture through a glass
pipette plugged with glass wool and air-dried (2). To the basic solution of the
TMPyPBr82+ in 0.1M NaOH was added excess LiPF6. A red solution formed
followed immediately by a precipitate. The solid was collected using a glass
pipette filtration system and air-dried. The resulting PF6- salt was then dissolved
in acetone by passing 1 mL aliquots of solvent through the glass-wool charged
with dried porphyrin. The solution was collected in a glass vial (~ 5 mL) and
transformed to the chloride salt by addition of excess nBu4Cl. The resulting
precipitate was collected using the glass pipette filtration and air-dried (Scheme
6).

Scheme 6. Synthesis of LiTMPyPBr83+ under ambient conditions
The absorption spectrum of the LiTMPyPBr83+ is shown in Figure 7.
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530 nm

Figure 7. Absorption spectra of Li+ porphyrin derivative (pH 11)
Approximately 2 mg of LiTMPyPBr83+ in 1 mL of pH 7 solution was added to
an aqueous solution of GdCl3 at room temperature. The mixture immediately
changed from red to yellow-green. Addition of excess NH4PF6 formed a green
precipitate that was collected using the glass pipette filtration system. The solid
was air-dried (Scheme 7).

Scheme 7. Reaction between Gd(III) ion and LiTMPyPBr83+
The absorbance showed a Soret band at 455 nm (Figure 8).
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455
nm

Figure 8. Absorbance spectrum of reaction product between Gd(III) ion
and LiTMPyPBr83+ (pH 7)
RESULTS AND DISCUSSION
The project design for a more facile synthesis of the GdTMPyPBr85+ was based
on a transmetallation reaction between the lithium porphyrin derivative and
Gd(III) ion which was a modified reaction approach to our previous report on
the synthesis of GdTMPyPBr85+.10 To advance this reactivity, the LiTMPyPBr83+
precursor was prepared using a multistep synthetic scheme.
Table I demonstrates that bromination of the starting material, H2TMPyP4+,
resulted in the shift of the porphyrin absorption spectrum from 425 nm to 503
nm. Deprotonation of H3TMPyPBr85+ in aqueous base resulted in the purple
TMPyPBr82+ species presumably due to delocalization of the negative charges at
the core nitrogen atoms and solvation of the dianionic species in polar solvent.
Subsequent metallation with lithium ion transformed the color from purple
to pink, consistent with previous studies using curve-fitting analyses and 7Li
NMR that established the formation of a mono-lithium porphyrin species.12
Bromination was likely required for the subsequent insertion of the Gd(III)
ion since β-substitution afforded a saddle-shaped macrocycle with a core large
enough to bind the Gd(III) ion.
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Table I: Absorption spectral data of synthesized porphyrins and metal
derivatives
Porphyrin		
λmax (nm; pH 7)
Color
H2TMPyP4+			
425
red
CuTMPyP4+			
425
red
CuTMPyPBr84+			
457
green
H3TMPyPBr85+			
503
brown-black
TMPyPBr82+			
579
purple
LiTMPyPBr83+			
530-538
red-pink
GdTMPyPBr85+			
455-463
green
The UV-visible spectrum of the reaction product between the lithium porphyrin
derivative and Gd(III) ion was consistent with our findings for the synthesis
of GdTMPyPBr85+ and resembled the absorption profile of transition metal
derivatives of the H3TMPyPBr85+.13 Our preliminary results indicate that we can
efficiently prepare and use the LiTMPyPBr83+ as a precursor for transition metal
ion complexes and the Gd(III) porphyrin.
CONCLUSIONS AND OUTLOOK
We plan to further characterize the Gd(III) complex via NMR spectroscopy
and powder diffraction analysis. Thereafter, the photophysical properties of the
GdTMPyPBr85+ will be investigated to determine its interaction with dioxygen.
A scale-up of the LiTMPyPBr83+ product as the solid hexafluorophosphate salt
was confounded during the precipitation stage, presumably due to reactivity of
the anion in aqueous base. Therefore, this reaction will be revisited.
ACKNOWLEDGEMENTS
T.X. would like to acknowledge the Department of Chemistry, Physics, and
Astronomy Chemistry Scholars Program and the Young Scientists Academy
and the Science Education Center at Georgia College for research support. T.S.
gratefully acknowledges research support from the Kaolin Science Education
Endowment at Georgia College. G.J. is grateful for support from the Young
Scientists Academy at Georgia College and the Georgia Military College Bull
Dog Club. C.J. would like to acknowledge the American Chemical Society
Project SEED summer research program and the Middle Georgia Section of
the American Chemical Society for funding. R.A.R. gratefully acknowledges
funding from the Faculty Research Grant program at Georgia College.

81

The Corinthian: The Journal of Student Research at Georgia College
REFERENCES
1.
Jemal, Ahmedian; Siegel, Rebecca; Xu Jiaquan. Cancer Statistics, 		
2010. A Cancer Journal for Clinicians. 60, 5, 277-300.
2.
Porphyrin-based Photosensitizers for Use in Photodynamic Therapy. 		
Sternberg, E. D.; Dolphin, D.; Brickner, C. Tetrahedron 1998, 			
54, 4151-4202.
3.
Kadish, K.M.; Smith, K.M.; Guilard, R., Eds. The Porphyrin 			
Handbook, Vol.1, Synthesis and Organic Chemistry. 				
Academic Press: New York, NY, 2000.
4.
Kadish, K.M.; Smith, K.M.; Guilard, R., Eds. The Porphyrin 			
Handbook, Vol. 6, Applications: Past, Present, and 				
Future. Academic Press: New York, NY, 2000.
5.
Adler, A.D. The Chemical and Physical Behavior of Porphyrin 		
Compounds and Related Structures; New York Academy 			
of Sciences: New York, NY, 1973.
6.
(a) Goldman, M.P. Photodynamic Therapy: Information on 			
Gadolinium-Containing Contrast Agents. Elsevier Science: 			
Philadelphia, PA, 2005. (b) Stark, D.D.; Bradley, 				
W.G. Magnetic Resonance Imaging; C.V. Mosbey: New York, 			
NY, 1988.
7.
Information for Healthcare Professional. Gadolinium-Containing 		
Contrast Agents for Magnetic Resonance Imaging. U.S. Food and 		
Drug Administration. http://www.fda.gov/ederdrug/infopage/			
gcca/default.htm. (accessed October 20,2011)
8.
Gd(III)-Based Contrast Agents for MRI. Aime, S.; Botta, M.; Terreno, 		
E. Adv. Inorg. Chem. 2005, 57, 173-237.
9.
(a) Porphyrin-based Sensitizers in the Detection and Treatment 		
of Cancer: Recent Progress. Vicente, M.G.H. Current Medicinal 		
Chemistry - Anti-Cancer Agents. 2001, 1, 175-194. (b) Motexafin 		
Gadolinium Cancer Treatment Product Candidate. 2008. 			
Pharmacyclics. http://www.pharmacyclics.com/wt/page/			
xcytrin. (accessed October 19, 2011).
10.
Synthesis of a Novel Gadolinium (III) Porphyrin as a Contrast Agent 		
and Photosensitizer in Tumors. Owens, J. H.; Richards, R. A. 			
The Corinthian. 2009¸ 10, 407-420.
11.
(a) Synthesis and characterization of lithium, sodium, and potassium
porphyrin complexes. X-ray crystal structures of Li2(C6H12O2)2TMPP,
Na2(THF)4OEP, and K2(pyridine)4OEP. Arnold, J.; Dawson, D.; 		
Hoffman, C. J. Am. Chem. Soc. 1993, 115, 2707-2713. (b) New
Lithium Porphyrin Derivatives: Synthesis of Li2(P)(Et2O)2 (P = 		
TTP, TBPP) and Solution Structure of Li2(TTP)(Et2O)2 by 7Li and 15N 		
82

Progress Towards A Facile Synthesis of a Gadolinium (III)

12.

13.

NMR. Brand, H.; Capriotti, J. A.; Arnold, J. Inorg. 				
Chem. 1994, 33 4334–4337. (c) Metal Complexes 				
with Tetrapyrrole Ligands, LIX – Redox Potentials, 				
Near-Infrared Absorption, Ionic Radii, and 					
Ring-Ring Distance in Metal(III) Bis(tetraphenylporphyrinate) 		
Systems with Porphyrin Rings in Different Oxidation States. Buchler, 		
J.W.; Hiittermann, J.; Loffler, J. Bull. Soc. Chem. 				
Jpn. 1988, 61, 71-77. (d) Lithium complexes and the kinetics 			
of interactions of zinc ions with tetra(N-methyl-4-pyridyl) porphyrins 		
in basic solution. Islam, M. Q.; Hambright, P. Trans. Met. Chem. 1998, 		
23, 727-733.
(a) Rosalie. R.; Hammons, K.; Joe, M.; Miskelly, G. M. Observation of 		
a Soluble Water-Soluble Lithium Porphyrin. Inorg. Chem., 			
1996, 35, 1940-1944.(b) Jadol, G; Debesai, K; Shoman, T; Rosalie, 		
R. Air-stable lithium porphyrin intermediates: Pathways to 			
metallocomplexes. Paper presented at the Sixth International 			
Conference on Porphyrins & Phthalocyanines, Albuquerque, 			
New Mexico. July 4-9, 2010.
Richards, R; Miskelly, G., Unpublished results.

83

